Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Citigroup Inc (C), Morgan Stanley (MS), JPMorgan Chase & Co. (JPM), And How the Revolving Door Leaves Investors Out to Dry

Why would banks like Citigroup Inc (NYSE:C), Morgan Stanley (NYSE:MS), JPMorgan Chase & Co. (NYSE:JPM), and Goldman Sachs Group, Inc. (NYSE:GS) have policies that offer special financial benefits to employees taking government positions — financial benefits that are usually reserved for employees who continue to work for the company?

Citigroup Inc. (NYSE:C)

Like most business decisions, I suspect these businesses are guided by the expectation that they will get a return on their investment in these former employees. The question is — what are these businesses getting? And do these compensation policies fuel a revolving door that compromises investors’ interests?

Public policy influence
The Project on Government Oversight (POGO) presents a compelling argument that the revolving door between the SEC and the private sector played a significant role in derailing tighter regulation of money market funds proposed last year. Several SEC alumni helped financial institutions lobby to derail the regulation. Key actors included:

Justin Daly, who formerly served as a counsel to an SEC Commissioner, lobbied against the rules on behalf of industry association Investment Company Institute.

Karrie McMillan formerly worked in the SEC’s Division of Investment Management, which is responsible for overseeing money market funds. McMillan also objected to the proposed rules on behalf of the Investment Company Institute.

Susan Ferris Wyderko, who once occupied the top job in the SEC’s Division of Investment Management, objected to the rules on behalf of industry group Mutual Fund Directors Forum.

In the end, POGO argues that the financial industry tipped the balance against the regulation by convincing Democratic commissioner Luis Aguilar to break ranks and join the Republican commissioners against the new regulations.

How did this happen? POGO argues that it has something to do with Aguilar’s close ties to the financial industry.

In early 2012, representatives from Aguilar’s former employer, Invesco Ltd. (NYSE:IVZ), met with Aguilar to present its argument that the proposed regulations were “extreme,” that the “current reforms are working,” and that the new regulations would “disrupt market functioning and damage a fragile economic recovery.”

When Aguilar presented his own arguments against the legislation, he repeated Invesco’s worry that the regulations could harm “the fragile state of the economy.” He also shared concerns that that the proposed regulations would cause investors to move their money to less-transparent and less-regulated markets — a common industry objection also pushed by SEC alumni Wyderko and McMillan.

Regulatory capture
While this case doesn’t necessarily involve a financial exchange, it highlights the risks associated with the revolving door between the public and private sectors. It suggests that public officials may be more receptive to arguments posed by the industry they previously worked for.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.